|
|
14 ch. des Aulx
Geneva 4, 1228 Switzerland
phone:(41) 22 839 71 41
fax:+41 22 839 71 42
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.novimmune.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutic agents for immune-related disorders and inflammation. |
|
| Management |
| Jack Barbut, ScD., Chief Executive Officer; Marie Kosco-Vilbois, PhD., Chief Scientific Officer; Penny Ward, MD., Chief Medical Officer; Arnd Christ, Chief Financial Officer; Nathalie Muller, LLB, Director, Human Resources and Administration |
| |
|
|
| |
|
| Keywords |
| drug, agents, immune, inflammation, autoimmune, rheumatoid, arthritis, multiple, sclerosis, Diabetes, blood sugar, diabetic, metabolic, insulin, psoriasis, inflammation, organ, transplantation, immunosuppression |
|
|
|
| Description |
|
NovImmune is focused on the development of therapeutic agents for immune-related disorders and inflammation. This concerns a wide variety of therapeutic areas, ranging from autoimmune diseases (such as Rheumatoid Arthritis, Multiple Sclerosis, Diabetes and Psoriasis) to inflammation in general and organ transplantation (immunosuppression). |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members